Here are some of the top technology highlights covered at the American Diabetes Association's 2026 scientific conference in New Orleans. Broadening access to diabetes technology and developing new ...

GLP-1-based medications have revolutionized blood sugar and weight management, but they aren’t effective for everyone. Eli Lilly, which makes the GLP-1/GIP drug Mounjaro (tirzepatide), is currently ...

A review of how far GLP-1 agonists have come – drugs for type 2 diabetes that help with not only blood sugar management, but with weight loss and heart health too GLP-1 agonists entered the type 2 ...

T1D Scout founder Yuta Matsuda explains how the swab-based, at-home genetic testing he developed works – and how it can help more families access type 1 diabetes screening. Type 1 diabetes screening ...

Control-IQ+ is an automated insulin delivery system used in Tandem's t:slim X2 and Mobi insulin pumps. The algorithm adjusts basal insulin every five minutes to prevent highs and lows. Automatic ...

Many people with diabetes struggle to manage mealtime blood sugar levels, even with new advances in technology. In a clinical trial of adults with type 1 diabetes, the inhaled insulin Afrezza ...

Tandem’s much-awaited Mobi automated insulin delivery system is available in the U.S. The Tandem Mobi is the world’s smallest insulin delivery system to be fully controllable by a smartphone. Now with ...

Because GLP-1 receptor agonists slow down digestion, they may delay the absorption of oral medications like birth control pills, which could affect ovulation and fertility. As more people begin taking ...

This educational article was made possible with materials and support from Tandem Diabetes Care. Automated insulin delivery (AID) systems have been traditionally used by people with type 1 diabetes ...

Microdosing is the off-label use of GLP-1 receptor agonists at doses lower than those approved for the treatment of diabetes or obesity. There are numerous reasons people may explore microdosing, ...

Trial Sponsor: SAB Biotherapeutics, Inc. Why is this study important? This study is testing the effectiveness of a new antibody drug, SAB-142, for slowing the progression of stage 3 type 1 diabetes, ...

Physical activity is an important part of blood sugar management but there are barriers to getting enough, a big one being a fear of hypoglycemia. AID systems have helped make exercise safer for ...